Modern Radiotherapy: From Palliation to Cure
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 4953
Special Issue Editor
Interests: radiation oncology; stereotactic body radiotherapy; lung cancer; hepatocellular carcinoma; cancer prevention
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Until the 2000s, radiation therapy was mainly used for symptom relief or adjuvant purposes before and after surgery. Of course, symptom relief or minimizing recurrence via multidisciplinary approach are important goals of radiation therapy. With the help of new developments around radiotherapy technology, it has become feasible to irradiate tumors with ablative high doses without overwhelming serious toxicities. The latest stereotactic radiotherapy techniques are used for curative purposes in various cancers, such as liver cancer, lung cancer, and prostate cancer. Furthermore, stereotactic radiotherapy is an effective and non-invasive local modality that can improve the oncological prognosis for oligometastatic disease, which involves ≤3 or 5 metastatic lesions. The introduction of precise radiosurgery techniques or particle therapy has enabled effective therapeutic intervention for recurrent cancer as well. In this Special Issue, we will discuss the role of radiation therapy as a palliative modality or multidisciplinary component, as well as a novel curative option or salvage modality for oligometastasis or recurrent cancer.
Dr. Chai Hong Rim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stereotactic body radiotherapy
- stereotactic radiosurgery
- oligometastasis
- cancer
- recurrent cancer
- proton therapy
- particle therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
